1. Background
Walnut tree (Juglans regia L.), belongs to family Juglandaceae (1). Walnut contains up to 62% - 68% oil, containing a high amount of monounsaturated and polyunsaturated fatty acids (2). Walnut leaves are considered as a source of healthcare compounds and are intensely used in traditional medicine to treat venous insufficiency and haemorrhoidal symptoms; it is also used for its antidiarrheic, antihelminthic, depurative and astringent properties (3-5).
This valuable tree has a long history of medicinal use to treat a wide range of health complaints. Almost all parts of the plant are medicinally important. Dry seeds (nuts) are very popular and largely consumed as royal food in Iran. In addition, green walnuts, shells, bark, green husks (epicarps), and leaves are used in the cosmetic and pharmaceutical industries (6). The stem bark is reported to be alterative, anthelmintic, astringent, bactericidal, depurative, digestive, diuretic, laxative, detergent, stimulant, tonic and insecticidal (7).
Walnut oil is a component of dry skin creams, anti-wrinkle and anti-aging products, because it presents moisturizing properties as well as free radical scavenging capacity (8).
In an experimental study, treatment of J. regia extracts in the experimental animal samples resulted in a significant decrease in blood glucose, glycosylated hemoglobin, low-density lipoprotein (LDL), triglyceride and total cholesterol and a significant increase in insulin and high-density lipoprotein (HDL) level (9).
Diabetes mellitus (DM) is a major public health problem. DM as well as its fatal complications is an important cause of death all over the world (10). For a very long time, plants have played an important role in the treatment of many chronic diseases, including DM (11). Use of plants to treat DM is common in Iranian population too. World health organization (WHO) has recommended the evaluation of effective plants for diseases such as diabetes, for which there are few safe modern drugs.
Iranian people with diabetes extensively use the extract of walnut and its hydrosol to control their blood sugar (BS). Some of these patients are satisfied with this herbal product and tolerate it well. However, there are few data about its effectiveness and safety (12, 13). Therefore, more studies are required to determine the effects and side effects of walnut on diabetes.
The only study on the effect of walnut extract on glycemic control in patients with type 2 diabetes showed a significant increase of insulin level and decrease of glycosylated hemoglobin (13). According to the literature research, no such study is conducted on patients with type 1 diabetes.
2. Objectives
For this reason, authors conducted a pilot study on the efficacy and safety of walnut extract (WLE) in patients with type 1 diabetes.
3. Materials and Methods
3.1. Plant Material and Extraction of Essential Oils
Walnut hydrosol was obtained from a local market in Meymand, Fars province, Iran. The essential oil of the sample was extracted using a liquid extractor in two stages. At first, 500 mL of the sample was mixed with 500 mL of petroleum-ether as a solvent. The solvent was heated to 45°C for 150 minutes and the essential oil was transformed from an aqueous phase to a petroleum-ether phase. The remains of the organic phase from the first stage were removed and additional amount (500 mL) of fresh petroleum-ether was added to the system. Similar to the first stage, it was heated for 150 minutes. This stage was carried out to increase the yield of the essential oil in the organic phase.
3.2. Essential Oil Concentration
The extracted essential oil was concentrated by rotary evaporator equipped with a vacuum pump. In this process, 500 mL of petroleum-ether containing the essential oil was heated to 40°C and vacuumed by rotation of a pump motor at 60 rpm, evaporating the petroleum-ether and leaving the extract. This process produced approximately 50 mL of the sample dissolved in a small amount of organic phase.
3.3. Gas Chromatography-Mass Spectrometry
The concentrated essential oil was dehydrated and subjected to gas chromatography mass spectrometry (GC/MS) for analysis of the constituents (Agilent Technologies 7890 gas chromatograph coupled with an Agilent Technologies model 5975C mass detector, Palo Alto, CA) (14). The apparatus was equipped with a HP-5ms capillary column [phenyl-methylsiloxane, length 30 m × inner diameter 0.25 mm, Agilent technologies (60 - 325/350°C)]. The oven temperature increased from 60°C (0 minute) to 220°C in increments of 5°C/minute and held at that temperature for 10 minutes. Helium was selected as the carrier gas and the flow rate was adjusted at a rate of 1 mL/minute. The mass spectrometer operated in EI mode at 70 eV. The interface temperature was 280°C and the mass range was 30 - 600 m/z. Retention indices were determined by using retention time of n-alkanes injected after the essential oil under the same chromatographic conditions. The components of the oil were identified by calculation of Kovat’s indices (KI) and comparison of their mass spectra with those of Wiley library or the published ones (15, 16).
3.4. Patients
As a pilot study, eight patients with type 1 DM were enrolled in the study. Inclusion criteria were type 1diabetes, age over 12 years old, completed puberty, having diabetes for more than two years and use of insulin analogs including Lantus SoloSTAR® Pen and NovoRapid® FlexPen to control diabetes. Subjects who used medicines other than insulin, those afflicted with other associated diseases and those who used insulin types other than Lantus SoloSTAR® Pen and NovoRapid® FlexPen were excluded from the study. Written informed consent letters were taken from all subjects. They were advised to measure their BS level at least four times daily by glucometer and record their BS level and insulin doses for at least two weeks. Then, the patients were advised to drink 250 mL WLE after meals twice a day. They continued to measure and record their BS level and insulin doses. During the study, the subjects used just insulin as anti-diabetic medication.
The subjects were called frequently to evaluate compliance and any complications and also to adjust the dosage of insulin injection. After four weeks, the use of WLE was stopped, subjects were examined by a physician, and the data including BS levels and injected insulin doses were collected. The subjects continued measuring and recording their BS levels and insulin doses for two more weeks. At that time, the subjects were examined again and the data were collected. Insulin doses and BS levels were compared for each patient before and after consuming WLE.
4. Results
The constituents of the essential oil of Juglans regia L. are presented in Table 1. Several compounds were identified in the oil and the rate of monoterpenoid and sesquiterpenoid compounds were 53.45% and 5.95%, respectively; also, the rate of phenolic compound was 51.34%. The main constituents of the oil were carvacrol (33.21%), thymol (16%), and homoveratrole (15.83%).
| Components | Content, % | KI (HP-5) | Identification |
|---|---|---|---|
| Homoveratrole | 15.83 | 1239 | MS, KI |
| Piperitone | 2.11 | 1257 | MS, KI |
| Thymol | 16 | 1291 | MS, KI |
| Carvacrol | 33.21 | 1301 | MS, KI |
| Eugenol | 2.13 | 1359 | MS, KI |
| γ-eudesmol | 5.95 | 1630 | MS, KI |
| Nonadecane | 3.12 | 1899 | MS, KI |
| Total identified | 78.35 | - | - |
| Monoterpene hydrocarbons | 53.45 | - | - |
| Sesquiterpene hydrocarbons phenolic compounds | 5.95 51.34 | - | - |
The Components of Juglans regia L. Essential Oila
All the eight subjects completed the study with no further dropout. Two of them were male and six were females with the age range of 13 - 25 years, and the mean age of 19.7 years. Table 2 shows the effect of WLE on average daily BS level and insulin dose of each subject. Five subjects had a decrease in both insulin dose and average daily BS level. Two other subjects showed a decrease only in average daily BS level, but because their BS level was in a favorite range, they did not decrease the insulin doses. In one other subject, the decrease in the average daily BS level was only 5 mg/dL, which was insignificant.
| Case No. | Average Daily BS | Average Daily Insulin Dose | Duration of Therapy, w | Side Effects | ||
|---|---|---|---|---|---|---|
| Before Use | During Use | Before Use | During Use | |||
| 1 | 164 | 140 | 42 | 37 | 4 | None |
| 2 | 160 | 148 | 38 | 34 | 4 | None |
| 3 | 154 | 136 | 32 | 27 | 4 | Skin rash |
| 4 | 172 | 150 | 45 | 41 | 4 | None |
| 5 | 190 | 170 | 36 | 36 | 4 | None |
| 6 | 183 | 178 | 40 | 40 | 4 | None |
| 7 | 161 | 130 | 44 | 36 | 3 | Hypoglycemic coma |
| 8 | 208 | 194 | 24 | 24 | 2 | Skin rash |
Efficacy and Side Effects of Walnut Extract in Patients With Type 1 Diabetes
Five of the subjects tolerated the extract very well without any complications. However, a few days after WLE consumption, two subjects called one of the authors and complained about development of generalized pruritic erythematous rashes. The rashes were mild and non-progressive in one of them; therefore, she continued WLE consumption, but the other subject stopped using WLE after two weeks due to progressive and troublesome skin rashes. One subject had severe hypoglycemia leading to coma after three weeks of using WLE. The subject followed her usual program of eating, insulin injection and physical activity. She did not have any illness before the attack of hypoglycemia, and overall, there was no other risk factor for hypoglycemia for her. Therefore, hypoglycemia was probably the consequence of WLE consumption. The level of consciousness was improved in the subject after a few hours and she was discharged from hospital without any side effects.
Two weeks after stopping WLE use, insulin doses and average BS level of all subjects increased again to nearly the level before using WLE.
5. Discussion
Juglans regia belongs to the family Juglandaceae. It includes three species: J. nigra, J. cinerea and J. regia although only J. regia grows in Iran (17). The key chemical composition of walnut is Juglone (5-hydroxy-1, 4-naphthoquinone), the toxic compound which is found only in green and fresh walnuts, but such property disappears in dried leaves (18). Several other phenolic compounds with antioxidant properties are identified in J. regia leaves (19).
Walnut (Juglans regia L.) is a plant with a significant economic value and medicinal importance for human health. It is consumed in large quantities by people; therefore, it has a very important place in the public nutritive habits (20). Leaves of J. regia are widely used in folk medicine to treat venous insufficiency and haemorrhoidal symptoms, for their antidiarrheic, antihelmintic, depurative, and astringent properties; mix of leaves and stored-grains are also used as fungicide and insecticide (21, 22). Other properties such as antibacterial, human cancer cell antiproliferative, antioxidant, keratolytic, antifungal, hypoglycemic, hypotensive, anti-scrofulous and sedative are also reported for this plant (19, 23-25). The beneficial effect of walnut consumption against many diseases is reported, including protection from diabetes (26) or cardiovascular diseases (27). Researches have also shown that eating walnuts can improve the blood lipid profile (28). Other investigations showed that J. regia extract contains ellagitannins, which is an anti-cancer agent with anti-inflammatory effects (17).
There are several reports regarding the analysis of walnut tree from different places. Examples are phytochemical analysis of the leaf volatile oil of walnut tree (29), studying about protein fractionations, amino acid composition, molecular weight distribution and gel electrophoresis of Juglans regia L. (30), surveys on antioxidant and antibacterial activities of the leaf essential oil of Juglans regia L. and its constituents (31), determination of mineral contents of Juglans regia L. flowers and its anti-hemolytic activity. Also, another study reported that J. regia improves glycemic level in the patients with type 2 diabetes, without any adverse effects on the kidney and hepatic function (14).
In another study (29), the volatile oils of all 28 J. regia populations were analyzed by gas chromatography flame ionization detectors (GC/FID) and gas chromatography mass spectrometry (GC/MS). Major components of the essential oils in this research were (E)-caryophyllene (1.4% - 47.9%), β-pinene (4.5% - 39.5%), germacrene-D (5.0% - 23.3%), α-pinene (1.5% - 18.1%), α-humulene (1.1% - 11.8%), α-zingiberene (0.1% - 11.3%), α-copaene (0.0% - 10.1%), limonene (0.8% - 8.6%), caryophyllene oxide (0.1% - 8.6%), ar-curcumene (0.0 - 7.2%), δ-cadinene (0.3% - 6.7%), (E)-β-farnesene (0.0% - 5.9%), 1, 8-cineole (< 0.0 - 5.4%), γ-curcumene (0.0 - 4.2%), methyl salicylate (0.1% - 4.0%), (E)-myrtanol acetate (0.0 - 3.8%), (E)-muurola-3, 5-diene (0.0 - 3.8%), (E)-β-ocimene (0.6% - 3.9%), α-longipinene (0.0 - 3.0%), myrcene (0.2% - 2.6%), α-muurolene (0.1% - 2.5%), spathulenol (0.0 - 2.2%) and α-cadinol (0.1% - 2.0%) (29).
A single report on volatile compounds (head space analysis) of J. regia leaves from Egypt showed the presence of germacrene-D (28.6%), and methyl salicylate (16.8%) as the main constituents (32). β-pinene (30.5%), β-caryophyllene (15.5%), α-pinene (15.1%), germacrene-D (14.4%) and limonene (3.6%) were identified as the principal components of the essential oil of walnut leaves from Kashmir (31). In another research, the essential oil was obtained by headspace method and the volatile compounds were pentanal (0.07 - 0.12%), hexanal (0.26 - 0.80%), nonanal (0.34 - 0.89%) and 2-decenal (0.25 - 0.68%) and hexanol (0.21 - 1.58%) (33). This research indicated that the percentage of aldehyde compound is higher than that of alcoholic compound.
A difference was found between the current study data and those of other reports. These differences can be due to ecological factors or species variations.
According to the current study searches in database, this is the first pilot study to determine the effect of WH on glycemic control in subjects with type 1 diabetes. Previously, only one study was conducted on the effect of walnut extract on patients with type 2 diabetes and several similar studies on animals with diabetes. WLE caused improvement of glycemic control both in rats with diabetes and patients with type 2 diabetes (14, 34).
In the present study, glycemic level controlled in most of the subjects with type 1 diabetes. The mechanism of glucose lowering effect of walnut is not clear. Some in vitro studies are performed to find the mechanisms. Most of these studies are conducted on type 2 diabetes. They concluded that walnut may cause increased release of insulin from beta cells, increased insulin sensitivity, or may interfere with absorption of dietary carbohydrate (34, 35). The pathophysiology of T1DM is completely different from that of type 2 diabetes. In T1DM, most of beta cells are destroyed; therefore, many agents that can help patients with type 2 diabetes are not efficacious in T1DM.
The key compounds responsible for anti-hyperglycemic effect of WLE may be phenolic compounds. Phenolic acids and flavonoids are two major groups of phenolic compounds existing in walnut leaves. As it was mentioned, seven components were found in WH. According to the current study investigation on these components, two of them with anti-hyperglycemic effect have been mentioned in other studies. Therefore, carvacrol or thymol or both of them may have an anti-hyperglycemia role but further studies are needed to investigate the cases. In an animal study, carvacrol in combination with rosiglitazone caused improvement in blood glucose and glycosylated hemoglobin high fat diet induced type 2 diabetes in mice (36). Another animal study revealed the anti-hyperglycemic effect of methanol extract of Otostegia persica Boiss (Labiatae) on rats with type 1 diabetes. Phytochemical analysis revealed thymol as the major component of the extract. More extensive studies are needed to determine the exact mechanism of anti-hyperglycemic effect of WLE.
Walnut extract was not associated with any complications in animals and patients with type 2 diabetes (14, 34), but its side effects were important among the current study subjects. Two of the subjects showed drug reactions as skin rashes, and one of them developed severe hypoglycemia. Drug reaction at least partially may be due to technical problems in providing the extract leading to an impure extract. Therefore, in leading studies, this process should be performed with more caution to prevent adding impurities. Hypoglycemia was a serious complication in one of the subjects. No other etiology was found for hypoglycemia in this subject and, therefore, hypoglycemia was probably the result of WH consumption. This complication can be an important limiting factor for extended use of the extract in human.
5.1. Conclusions
WH may control glycemic level in human, but it can be associated with minor and major side effects. Seven compounds were identified in walnut oil. According to the current study search, among these components two of them (thymol and carvacrol) may have an anti-hyperglycemia effect mentioned in other studies. Therefore, WH should not be advised extensively to people with diabetes until the knowledge is increased about its mechanism of action and potential side effects. Further studies are needed.
The most important limitation of this study was the low number of participants. According to the severe side effects in one of the subjects, it is not suggested to perform this study on larger population. However, new in vitro studies are recommended to determine the mechanism of WH effect on blood sugar in subjects with type 1 diabetes mellitus.
